C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 31/70 (2006.01) A61K 38/17 (2006.01) A61K 48/00 (2006.01) C07K 14/47 (2006.01) C07K 16/18 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2238670
sMAD3d polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing sMAD3d polypeptides and polynucleotides in the design of protocols for the treatment of chronic renal failure, atherosclerosis, and fibrosis, among others, and diagnostic assays for such conditions.
Divulgation de polypeptides et de polynucléotides sMAD3d, ainsi que de méthodes de production de tels polypeptides par des techniques de recombinaison. Des méthodes pour utiliser les polypeptides et les polynucléotides sMAD3d dans la conception de protocoles pour le traitement de l'insuffisance rénale chronique, de l'athérosclérose et de la fibrose, entre autres, de même que des épreuves diagnostiques pour ces conditions sont également dévoilées.
Laping Nicholas
Zhu Yuan
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
A novel smad3 splice variant as a target in chronic renal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A novel smad3 splice variant as a target in chronic renal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A novel smad3 splice variant as a target in chronic renal... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1517334